Last reviewed · How we verify
NCT07163806
Volumetric Parameter of 18F-FDG PET/CT in Characterizing Thyroid Incidentalomas
trial testing PET/CT with 18-FDG in Thyroid Incidentalomas in 88 participants. Not yet recruiting.
30 April 2028
Quick facts
| Lead sponsor | Fatma Abelzaher Mahmoud Ahmed |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 88 |
| Start date | 30 October 2025 |
| Primary completion | 30 April 2028 |
| Estimated completion | 30 May 2028 |
Drugs / interventions tested
- PET/CT with 18-FDG — full drug profile →
Conditions studied
- Thyroid Incidentalomas — all drugs for Thyroid Incidentalomas →
Sponsor
Fatma Abelzaher Mahmoud Ahmed
Who can join
Adults 18 to 90, any sex, with Thyroid Incidentalomas. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To assess the clinical significance of FDG-avid thyroid incidentalomas detected on PET/CT and explore correlations between SUV max, ultrasound characteristics, and histopathology for suspicious lesion.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07163806
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of PET/CT with 18-FDG
Trials testing the same drug.
- NCT07306975 — Comparative Analysis of SUV Measurements Using Different Correction Methods in Oncological PET/CT Imaging. · not yet recruiting
- NCT07010484 — Using Novel Imaging to Rethink Diagnostic and Treatment Strategies for Polymyalgia Rheumatica · recruiting
- NCT06629207 — Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder · NA · recruiting
- NCT06597045 — BIOMARKER and IMAGING CHARACTERISATION of INFLAMMATORY ATHEROMA in PATIENTS RECEIVING IMMUNOTHERAPY and ANGIOGENESIS INH · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07163806 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fatma Abelzaher Mahmoud Ahmed
- Last refreshed: 29 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07163806.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing